Cargando…

Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia

Detalles Bibliográficos
Autores principales:	Watanabe-Smith, Kevin, Tognon, Cristina, Tyner, Jeffrey W., Meijerink, Jules P.P., Druker, Brian J., Agarwal, Anupriya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014660/ https://www.ncbi.nlm.nih.gov/pubmed/27118405 http://dx.doi.org/10.1038/leu.2016.95

Ejemplares similares

Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations
por: Watanabe-Smith, Kevin, et al.
Publicado: (2017)

Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients
por: Rosenberg, Mara W., et al.
Publicado: (2020)

Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3 mutation-positive leukemia
por: Agarwal, Anupriya, et al.
Publicado: (2014)

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia
por: Khanna, Vishesh, et al.
Publicado: (2015)

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
por: Joshi, Sunil K., et al.
Publicado: (2020)

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia
por: Dao, Kim-Hien T., et al.
Publicado: (2014)

Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer
por: Rashid, Mamoon, et al.
Publicado: (2021)

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
por: Kurtz, Stephen E., et al.
Publicado: (2022)

Ultrasensitive proteomic quantitation of cellular signaling by digitized nanoparticle-protein counting
por: Jacob, Thomas, et al.
Publicado: (2016)

Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples
por: Edwards V, David K., et al.
Publicado: (2018)

FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells
por: Javidi-Sharifi, Nathalie, et al.
Publicado: (2019)

Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells
por: Javidi-Sharifi, Nathalie, et al.
Publicado: (2019)

In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia
por: Glover, Jason M, et al.
Publicado: (2012)

Functional characterization of two rare BCR–FGFR1(+) leukemias
por: Barnes, Evan J., et al.
Publicado: (2020)

Spectrum of germline RB1 mutations and clinical manifestations in retinoblastoma patients from Thailand
por: Rojanaporn, Duangnate, et al.
Publicado: (2018)

Spectrum of RB1 Germline Mutations and Clinical Features in Unrelated Chinese Patients With Retinoblastoma
por: Lan, Xiaoping, et al.
Publicado: (2020)

Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality
por: Rojanaporn, Duangnate, et al.
Publicado: (2022)

Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations
por: Nguyen, Ha Hai, et al.
Publicado: (2018)

Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report
por: Carratt, Sarah A., et al.
Publicado: (2021)

Comprehensive molecular characterization of a rare case of Philadelphia chromosome–positive acute myeloid leukemia
por: Rosenberg, Mara W., et al.
Publicado: (2022)

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
por: Tyner, J W, et al.
Publicado: (2012)

Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing
por: Zou, Yihua, et al.
Publicado: (2021)

Multiple QTL underlie milk phenotypes at the CSF2RB locus
por: Lopdell, Thomas J., et al.
Publicado: (2019)

Dissecting the role of CSF2RB expression in human regulatory T cells
por: Côrte-Real, Beatriz F., et al.
Publicado: (2022)

The PI3K/Akt1 pathway enhances steady-state levels of FANCL
por: Dao, Kim-Hien T., et al.
Publicado: (2013)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Complete Genome Sequences of T4-Like Bacteriophages RB3, RB5, RB6, RB7, RB9, RB10, RB27, RB33, RB55, RB59, and RB68
por: Yaung, Stephanie J., et al.
Publicado: (2015)

Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia
por: White, Brian S., et al.
Publicado: (2021)

Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms
por: Bochicchio, Maria Teresa, et al.
Publicado: (2023)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia
por: Adam, Franziska C., et al.
Publicado: (2022)

Germline mutations among Polish patients with acute myeloid leukemia
por: Bąk, Aneta, et al.
Publicado: (2021)

Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML
por: Gosline, Sara J. C., et al.
Publicado: (2022)

Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB
por: Takaki, Masahiro, et al.
Publicado: (2016)

CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma
por: Zhu, Ningning, et al.
Publicado: (2022)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

Discovery of cancer-preventive juices reactivating RB functions
por: Masuda, Mitsuharu, et al.
Publicado: (2023)

Rare evolution of CSF3R-mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with SETBP1 mutation
por: Hirao, Maki, et al.
Publicado: (2022)

BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
por: Hurtz, Christian, et al.
Publicado: (2011)

CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia
por: Cui, Yajuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_76opafd3q3j5m07mb1l9r8kirc